Potential of isothiocyanate sulforaphane from broccoli to combat obesity and type 2 diabetes: involvement of NRF2 regulatory pathway
Marian V. Ivanochko, Maria M. Bayliak, Volodymyr I. Lushchak
Abstract
Marian V. Ivanochko, Maria M. Bayliak, Volodymyr I. Lushchak
Abstract
Biologically active food components are now considered to be remedies for the prevention and treatment of metabolic disorders of different etiology. The aim of this review was to analyze the current data on the application of isothiocyanate sulforaphane, found in broccoli and other cruciferous plants, for the treatment of T2DM, obesity, and their comorbidities with the presentation of established molecular, particularly dependent on NF-E2-related factor-2 (Nrf2), and signaling mechanisms of therapeutic effects. Keywords: broccoli sprouts, Nrf2, nutritional therapy, obesity, preventive health, sulforaphane, type 2 diabetes mellitus
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Biologically active food components are now considered to be remedies for the prevention and treatment of metabolic disorders of different etiology. The aim of this review was to analyze the current data on the application of isothiocyanate sulforaphane, found in broccoli and other cruciferous plants, for the treatment of T2DM, obesity, and their comorbidities with the presentation of established molecular, particularly dependent on NF-E2-related factor-2 (Nrf2), and signaling mechanisms of therapeutic effects. Keywords: broccoli sprouts, Nrf2, nutritional therapy, obesity, preventive health, sulforaphane, type 2 diabetes mellitus
Key concepts: Sulforaphane, Isothiocyanate, Cruciferous vegetables, Brassica, Obesity, Glucosinolate, Medicine, Type 2 diabetes